About
Peptide-based active immunotherapy
Areas of Focus
Categories
Gene Therapy, RNA & Peptide Therapy
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
228
By Phase
PHASE2: 1PHASE1: 1
By Status
NOT_YET_RECRUITING: 1COMPLETED: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT06605963Lead Sponsor
PPV-06 Vaccine in Inflammatory Knee Osteoarthritis
PHASE2Not yet recruiting
204 participants
Started: Dec 31, 2025 · Completed: Dec 31, 2028
NCT04447898Lead Sponsor
Dose Escalation Study Assessing the Safety and Immune Response of PPV-06 Vaccine
PHASE1Completed
24 participants
Started: Feb 18, 2021 · Completed: Feb 28, 2023
Locations (1)
Headquarters
Paris, France
Map
Loading map...